Please note that all the applicants are requested to complete the payment of registration fee by the deadline of abstract submission. If you do not complete the payment of registration fee, your abstract will be withdrawn.
*If you live in Japan, please register from the Japanese screen.

• Oral/Poster Presentation

Please check the Criteria of COI below; At the time of abstract submission, you have to choose appropriate status of COI. If you choose Yes, it has to declare COI related matter on the presentation slide and also submit it.
Please also disclose the status of COI if you have nothing to declare.

Disclosure method

For oral session, include a self-disclosure of the state of COI in the second slide (following the title slide). In case of poster presentation, please disclose financial relationships on your research in the poster, referring to the examples of disclosure in oral presentation.

Sample slides are available here.

All human and animal studies must have been approved by the authors' institutional review board. All clinical investigation must have been conducted according to Declaration of Helsinki principles. Keep subjects' personal information confidential.

An applicant must:

• be a member of the Japanese Society of Toxicology
• be under the age of 35 as of March 31, 2025
• be a presenter of poster presentation (Award applicants are to do an oral presentation also on July 2, 2025)
• be pre-registered for the Congress and complete the payment of registration fee by the deadline of abstract submission
• obtain a visa for entering Japan prior to the Congress, if necessary.

An applicant must:

• be a member of the Japanese Society of Toxicology
• be undergraduate or graduate student (except for adult graduate student) as of July 2, 2025
• be a presenter of poster presentation,
• be pre-registered for the Congress and complete the payment of registration fee by the deadline of abstract submission
• obtain a visa for entering Japan prior to the Congress, if necessary.

The names of award winners will be announced during the Congress. The ceremony will take place on July 4, 2025 at the congress site. The award winners will receive a certificate and a prize.

*Please note that you are not able to apply both "Excellent Presentation Award" and "Student Poster Award".

We are planning to make a PDF file of Program & Abstract Book and printed material of Program & Abstract Book. Printed material of Program & Abstract Book will be distributed at the congress site.

The presenting authors must submit abstract by themselves who have the membership.
If you live in Japan, please register from the Japanese screen.
Click the "Go to Abstract Submission page" button on this page. We recommend you to register early, for the online submission system is likely to be heavily accessed as the deadline approaches.
Applicants registering for the first time are requested to make a new account entering their personal information first.
Read and follow the instruction on the screens, and fill in the required fields. The items you are required to fill in are as follows:

• Presenting author's personal information
• Name of authors (no more than 20 authors), affiliated institutions (no more than 15 institutions)
• Type of presentation (Oral/Poster/Either)
• Application for Excellent Presentation Award and Student Poster Award (ONLY for poster presenters)
  *Please note that you are not able to apply both "Excellent Presentation Award" and "Student Poster Award".
• Title of presentation (should be under 200 characters)
• Abstract body
  - It should be between 800-1600 characters (include spaces).
  - Do not include the title, names and institutions of authors.
  - It should NOT contain figure or table.
  - It must contain a brief, clear statement of conclusion.
• Category
  *Please select ONE.

  101	Pharmaceutical drugs (chemicals)	305	Behavioral toxicology
  102	Middle molecular drugs	306	Immunotoxicology
  103	Biopharmaceuticals	307	Drug dependency
  104	Regenerative medicine and cell therapy	308	Cytotoxicity
  105	Agricultural chemicals	401	Oxidative stress
  106	Metals	402	Inflammation
  107	Industrial chemicals	403	Mechanisms of toxicity
  108	Toxins	404	Cellular response
  109	Foods, food additives, and food contaminants	405	Molecular toxicology
  110	Environmental pollutants	406	Gene regulation
  111	Endocrine disruptors	407	Epigenetics
  112	Nanomaterials	408	Omics
  113	Radiation	409	Biomarkers
  114	Other materials	410	Toxicity-testing methods
  201	Nervous system	411	Analytical method
  202	Liver	412	Toxicokinetics
  203	Kidney	413	Toxicologic pathology
  204	Skin	414	Statistics
  205	Sensory organ	415	Alternatives to mammalian models
  206	Gastrointestinal system	416	Animal model
  207	Respiratory system	417	Epidemiology
  208	Cardio vascular system	418	Clinical toxicology
  209	Reproductive system	419	Hypersensitive subjects
  210	Endocrine system	420	Risk assessment and communication
  211	Other organs or system	421	Information technology, AI, and big data
  301	General toxicology	422	Organoid
  302	Reproductive and developmental toxicology	423	AOP（adverse outcome pathway）
  303	Genetic toxicology	500	Others
  304	Carcinogenicity

• COI disclosure

After finishing abstract submission, you will receive "notification message" to your registered e-mail address (ID) for confirmation. If you do not receive such an e-mail within 24 hours, please contact the Congress Management Office.

You can change/modify your abstract until the deadline of abstract submission by logging in to the Abstract Submission page.
After the deadline of the abstract submission, no modifications, changes, or additions whatsoever to the abstract body, authors (either first author or co-authors), or affiliations are permitted.
Please take great care to ensure that no mistakes are made before your submission.

Registered personal information use only for the annual meeting.
The information is protected and securely saved with necessary security.

The final decision to accept or reject the submitted abstracts will be made by the Organizing Committee. A notification of acceptance or rejection will be sent to each presenter by e-mail in April, 2025.

Firstly, please complete the early registration by the deadline of abstract submission.
Check the "Guide to Japanese VISA" through the URL below.
Ministry of Foreign Affairs of Japan (https://www.mofa.go.jp/j_info/visit/visa/index.html)
Please fill in the necessary documents for your VISA application and send by e-mail to the Congress Management Office. We will complete the documents and send back to you by mail.

Presenting authors must submit their abstracts by themselves.

Congress Management Office
E-mail: jsot52@senkyo.co.jp